Skip to main content
. 2024 Nov 27;8(6):zrae133. doi: 10.1093/bjsopen/zrae133

Table 1.

Patient characteristics

Conventional n = 427 No Touch n = 426
Age (years), median (range) 66 (23–80) 66 (33–80)
Sex
 Male 211 (49.4) 212 (49.8)
 Female 216 (50.6) 214 (50.2)
Eastern Cooperative Oncology Group performance status
 0 407 (95.3) 407 (95.5)
 1 20 (4.7) 19 (4.5)
Tumour location
 Right 193 (45.2) 191 (44.8)
 Left 234 (54.8) 235 (55.2)
Tumour depth
 cT3 298 (69.8) 281 (66.0)
 cT4a 113 (26.5) 122 (28.6)
 cT4b 16 (3.7) 23 (5.4)
Nodal status
 cN0 174 (40.7) 166 (39.0)
 cN1 177 (41.5) 183 (43.0)
 cN2 76 (17.8) 76 (17.8)
 cN3 0 (0.0) 1 (0.2)
BMI (kg/m2), median (range) 22.4 (12.8–30.0) 22.5 (13.8–29.8)
Tumour size (cm), median (range) 4.8 (2.0–13.5) 5.0 (0.7–14.0)
Pathological results
 Number of harvested lymph nodes, median (range) 28 (3–129) 28 (3–104)
 Pathological stage
  I 25 (5.9) 18 (4.2)
  II 181 (42.4) 188 (44.1)
  III 208 (48.7) 194 (45.9)
  IV 13 (3.0) 25 (5.9)
 Residual tumour
  R0 421 (98.6) 410 (96.2)
  R1 1(0.2) 5 (1.2)
  R2 5 (1.2) 10 (2.3)

Values are n (%) unless otherwise indicated.